Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

45.40
Delayed Data
As of Feb 23
 +0.39 / +0.87%
Today’s Change
36.76
Today|||52-Week Range
45.79
+18.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$77.8B

Company Description

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Contact Information

Abbott Laboratories
100 Abbott Park Road
Abbott Park Illinois 60064-6400
P:(224) 667-6100
Investor Relations:

Employees

Shareholders

Other institutional42.71%
Mutual fund holders35.04%
Individual stakeholders3.76%

Top Executives

Miles D. WhiteChairman & Chief Executive Officer
Brian B. YoorChief Financial Officer & Senior VP-Finance
Randel W. WoodgriftVP-Vascular, Manufacturing, Research & Development
James E. YoungChief Compliance & Ethics Officer, Vice President
Hubert L. AllenSecretary, Executive VP & General Counsel